Piper Jaffray Downgrades American Physicians Capital (ACAP) to Neutral
More News related to ACAP
- American Physicians Capital (ACAP) Approves 4-for-3 Stock Split; Adds Another $20M Authorization Under 10b5-1 Plan
- American Physicians Capital, Inc. Announces 4-for-3 Stock Split; Completes $20 Million Authorization and Approves Another $20 Million Authorization Under 10b5-1 Stock Repurchase Plan
- American Physicians Capital, Inc. to Present at the Fox-Pitt Kelton Cochran Caronia Waller Investor Conference on June 18, 2009
- American Physicians Capital (ACAP) Receives Approval for Extraordinary Dividend from Regulator
- American Physicians Capital, Inc. Receives Approval for Extraordinary Dividend from Regulator
Piper Jaffray & Co. downgrades American Physicians Capital (Nasdaq: ACAP) from Buy to Neutral. Price target $48.
Piper analyst says, "With shares rising roughly 40.0% over the last month, shares of medical malpractice insurer American Physicians Capital now trade in the top decile of historic valuations. As such, we see little upside in the shares and lower our rating from Buy to Neutral on ACAP. At current prices, shares trade at 1.7x current book value, well ahead of our target valuation multiple of 1.5x, and offer little upside to our $48 price target...We continue to believe our multiple of 1.5x remains appropriate given current and projected returns on equity in the range of 15.0%-16.0%. Meanwhile, our view on the company's and industry fundamentals remains unchanged as low claim frequency continues to benefit underwriters through favorable reserve development."
American Physicians Capital, Inc., (APCapital) is an insurance holding company that writes medical professional liability insurance through its primary subsidiary American Physicians Assurance Corporation (American Physicians).
Related Categories
DowngradesStocks Mentioned
-1.05Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
